Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001284260 | SCV001469942 | uncertain significance | not provided | 2020-01-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002537931 | SCV003537803 | uncertain significance | Inborn genetic diseases | 2022-06-30 | criteria provided, single submitter | clinical testing | The c.338A>G (p.Y113C) alteration is located in exon 5 (coding exon 4) of the VWF gene. This alteration results from a A to G substitution at nucleotide position 338, causing the tyrosine (Y) at amino acid position 113 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Center for Genomic Medicine, |
RCV003989670 | SCV004807469 | likely pathogenic | von Willebrand disease type 1 | 2024-03-26 | criteria provided, single submitter | clinical testing |